Perindopril Erbumine
特丁胺培哚普利
Report date: 2022/05/11 14:41:52
NME
Base Information
Drug NamePerindopril Erbumine
Drug Alias Name +[16]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/TerritoryN/A
Original Approved Date1988/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSymplmed
China Registration ClassN/A
Develop Information
Active CompaniesOril Industrie SasSymplmed
Inactive CompaniesSymplmed Pharmaceuticals LlcSichuan Haisco Pharmaceutical Co Ltd
Active Indications
Inactive Indications